Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial.

ABSTRACT:

SUBMITTER: Shaverdian N 

PROVIDER: S-EPMC5538772 | biostudies-literature | 2017 Jul

REPOSITORIES: biostudies-literature